Melinta Therapeutics, Inc. (NASDAQ:MLNT)

7.10
Delayed Data
As of Jun 22
 -0.35 / -4.70%
Today’s Change
5.20
Today|||52-Week Range
24.25
-55.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash99.1M153.8M231.6M128.4M
 
 
 
 
 
Short Term Investment Cash2.6M54.7M77.8M117.2M
 
 
 
 
 
Cash & Short Term Investments99.1M153.8M231.6M128.4M
 
 
 
 
 
 
ReceivablesReceivables2.4M7.6M6.2M7.6M
 
 
 
 
 
 
InventoriesInventories0.000.000.0010.8M
 
 
 
Current AssetsPrepaid Expenses3.4M572.6K579.0K--
 
 
 
 
Other Current Assets0.000.000.003.0M
 
 
Current Assets104.9M162.0M238.3M149.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross303.0K348.8K--10.6M
 
 
 
 
Depreciation-189.9K-259.1K---9.0M
 
 
 
 
Intangible Assets0.000.000.007.5M
 
 
Other Assets0.0073.2K173.0K8.7M
 
 
 
 
Total Assets105.3M162.1M238.5M160.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable11.9M9.6M15.7M7.4M
 
 
 
 
 
Short Term Debt3.6M4.4M6.7M0.00
 
 
 
 
Accrued Expenses788.0K863.9K2.3M14.2M
 
 
 
 
 
Other Current Liabilities1.0M1.5M2.9M14.4M
 
 
 
 
 
Other Liabilities18.1M17.9M29.5M31.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt14.9M15.3M8.7M39.6M
 
 
 
 
 
Other Liabilities0.000.000.006.6M
 
 
Total Liabilities44.3M44.5M55.2M87.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity61.0M117.7M183.3M72.3M
 
 
 
 
 
Total Shareholder Equity61.0M117.7M183.3M72.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding7.5M8.8M10.5M22.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.